COX-2 expression has been found to be upregulated in most human tumors including colon, lung, breast and prostate, which also attributes to cancer-related inflammation, tumor cell proliferation, resistance to apoptosis and angiogenesis [43]. This evidence concerns the gene PTGS2 and cancer.